Drugs / ALK HDM AIT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01433523 | Aug 2011 → Apr 2013 | asthma | ALK-Abelló A/S | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALK HDM AIT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01433523 ↗ |